Search research articles
Contact Us
Filters
Showing results (671-680 of 704) with videos related to
Page
of 71
Sort By:
Science (New York, N.Y.)
|
August 3, 2023
Peptide YY: A Paneth cell antimicrobial peptide that maintains <i>Candida</i> gut commensalism
Joseph F Pierre, Brian M Peters, Diana La Torre, et al.
Genes and Immunity
|
November 13, 2009
HLA-class I markers and multiple sclerosis susceptibility in the Italian population
L Bergamaschi, M A Leone, M E Fasano, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 4, 2020
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
Gary M Hunninghake, Luisa D Quesada-Arias, Nikkola E Carmichael, et al.
Cell Host & Microbe
|
February 4, 2026
HMGB1 functions as a critical mediator of host defense at the gut mucosal barrier
Anne-Marie C Overstreet, McKenzie Burge, Brady Anderson, et al.
Cell Host & Microbe
|
April 19, 2022
High-fat diet disrupts REG3γ and gut microbial rhythms promoting metabolic dysfunction
Katya Frazier, Amal Kambal, Elizabeth A Zale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer
B A Leone, C T Vallejo, A O Romero, et al.
Redox Biology
|
December 17, 2023
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
G Baron, A Altomare, L Della Vedova, et al.
Cell Death and Differentiation
|
April 2, 2016
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A Tosco, F De Gregorio, S Esposito, et al.
Cell Death and Differentiation
|
July 23, 2016
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A Tosco, F De Gregorio, S Esposito, et al.
Thorax
|
January 23, 2021
Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals
Nikkola Carmichael, Jose M Martinez Manzano, Luisa D Quesada-Arias, et al.
Page
of 71
Search research articles
Search
Showing results (671-680 of 704) with videos related to
Sort By:
Page
of 71
Science (New York, N.Y.)
|
August 3, 2023
Peptide YY: A Paneth cell antimicrobial peptide that maintains <i>Candida</i> gut commensalism
Joseph F Pierre, Brian M Peters, Diana La Torre, et al.
Genes and Immunity
|
November 13, 2009
HLA-class I markers and multiple sclerosis susceptibility in the Italian population
L Bergamaschi, M A Leone, M E Fasano, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 4, 2020
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
Gary M Hunninghake, Luisa D Quesada-Arias, Nikkola E Carmichael, et al.
Cell Host & Microbe
|
February 4, 2026
HMGB1 functions as a critical mediator of host defense at the gut mucosal barrier
Anne-Marie C Overstreet, McKenzie Burge, Brady Anderson, et al.
Cell Host & Microbe
|
April 19, 2022
High-fat diet disrupts REG3γ and gut microbial rhythms promoting metabolic dysfunction
Katya Frazier, Amal Kambal, Elizabeth A Zale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1996
Ifosfamide and vinorelbine as first-line chemotherapy for metastatic breast cancer
B A Leone, C T Vallejo, A O Romero, et al.
Redox Biology
|
December 17, 2023
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
G Baron, A Altomare, L Della Vedova, et al.
Cell Death and Differentiation
|
April 2, 2016
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A Tosco, F De Gregorio, S Esposito, et al.
Cell Death and Differentiation
|
July 23, 2016
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A Tosco, F De Gregorio, S Esposito, et al.
Thorax
|
January 23, 2021
Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals
Nikkola Carmichael, Jose M Martinez Manzano, Luisa D Quesada-Arias, et al.
Page
of 71